Kestrel Pharmaceuticals Private Limited
About Kestrel Pharmaceuticals Private Limited
Data last updated:
Kestrel Pharmaceuticals Private Limited is a private limited company based in Kozhikode, Kerala, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 29 November 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Ernakulam, under CIN U24239KL2018PTC055732. Its GSTIN is 32AAHCK3839R1ZY (Kerala).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹9.5 Lakh. It is led by directors including Priyesh Thena Parambil (Managing Director) and Nisha Prajeesh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Room No. 18/1084 G4 3rd Floor Meyon Building, Kozhikode, Kerala, India – 673004.
As per the financials filed for FY 2025, the company reported a revenue of ₹13.14 Lakh, a decline of 26% compared to the previous year. For the same year it recorded a net profit of ₹13,120 (net margin 1%) and EBITDA of ₹20,210 (EBITDA margin 1.5%). Revenue has grown at a compounded annual rate (CAGR) of 3% over three years and 9% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Kestrel Pharmaceuticals Private Limited's registered office is in Kozhikode, Kerala. Its e-mail address is in the company report.
- Email
- Registered AddressRoom No. 18/1084 G4 3rd Floor Meyon Building, Kozhikode, Kerala, India – 673004
- IndustryChemicals, Manufacturing, Other Chemical Product
To see the full contact details of Kestrel Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Kestrel Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Kestrel Pharmaceuticals Private Limited, buy the company report.
Financials of Kestrel Pharmaceuticals Private Limited
FY 2025 filings availableKestrel Pharmaceuticals Private Limited reported revenue of ₹13.14 Lakh (down 26% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 26% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 9%. EBITDA fell 63% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹20,210 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹13,120 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.5% | ||||
| Net Profit Margin | 1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Kestrel Pharmaceuticals Private Limited, buy the company report.
Board of directors of Kestrel Pharmaceuticals Private Limited
Kestrel Pharmaceuticals has 5 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nisha Prajeesh | Director | 20 Feb 2020 | 6 Years 8 Months | Current |
| Manju Krishna | Director | 12 Mar 2019 | 7 Years 7 Months | Current |
| Abhilash Thankappan | Director | 15 Oct 2019 | 7 Years 0 Months | Current |
| Priyesh Thena Parambil | Managing Director | 29 Nov 2018 | 7 Years 11 Months | Current |
| Vysakh Santhoshkumar Nair | Director | 29 Nov 2018 | 7 Years 11 Months | Current |
Peer comparison
Kestrel Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Healthcare industry (Healthcare Equipment Retail and Distribution, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| KBD Pharmaceuticals Private Limited | ₹13.15 Lakh (FY 2023) | 10.0% | Hyderabad, Telangana, India | |||
| Rochestox Life Sciences Private Limited | ₹13.14 Lakh (FY 2024) | -64.0% | Noida, Uttar Pradesh, India | |||
| Kestrel Pharmaceuticals Private Limitedthis company | ₹13.14 Lakh (FY 2025) | ₹13,120 | 1% | -26.0% | Kozhikode, Kerala, India | |
| Delmas Pharmaceuticals Private Limited | ₹13.12 Lakh (FY 2024) | 13.0% | Jaipur, Rajasthan, India | |||
| Gynus Pharmaceuticals Private Limited | ₹13.1 Lakh (FY 2025) | 0.0% | Allahabad, Uttar Pradesh, India |
To see the full peer comparison of Kestrel Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Kestrel Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Kestrel Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Kestrel Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 32AAHCK3839R1ZY | Kerala | Active | 13 Mar 2019 |
To see the full GST registrations and return filing status of Kestrel Pharmaceuticals Private Limited, buy the company report.
Recent activity
Kestrel Pharmaceuticals Private Limited has 8 board changes on record since 2018: 5 appointments and 3 cessations. The latest: Nisha Prajeesh ceased to be Additional Director on 30 Dec 2020.
Frequently asked questions
Kestrel Pharmaceuticals is an active private limited company based in Kozhikode, Kerala, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 29 November 2018 (8+ years old) and is registered under CIN U24239KL2018PTC055732.
Kestrel Pharmaceuticals has 5 current directors:
- Priyesh Thena Parambil - Managing Director
- Nisha Prajeesh - Director
- Manju Krishna - Director
- Abhilash Thankappan - Director
- Vysakh Santhoshkumar Nair - Director
The latest financial statements of Kestrel Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Kestrel Pharmaceuticals is 32AAHCK3839R1ZY, registered in Kerala.
The CIN (Corporate Identification Number) of Kestrel Pharmaceuticals is U24239KL2018PTC055732. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Kestrel Pharmaceuticals was incorporated on 29 November 2018, making it 8+ years old. It is registered with the Registrar of Companies, Ernakulam.
The peers of Kestrel Pharmaceuticals by revenue are KBD Pharmaceuticals Private Limited, Rochestox Life Sciences Private Limited, Delmas Pharmaceuticals Private Limited, Gynus Pharmaceuticals Private Limited, all in the Healthcare industry (Healthcare Equipment Retail and Distribution, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Nisha Prajeesh ceased to be Additional Director on 30 Dec 2020. Nisha Prajeesh was appointed as Director on 20 Feb 2020. Abhilash Thankappan ceased to be Additional Director on 31 Dec 2019. Kestrel Pharmaceuticals has 8 board changes on record in total.
The registered office of Kestrel Pharmaceuticals is at Room No. 181084 G4 3rd Floor Meyon Building, Kozhikode, Kerala, India – 673004.
Kestrel Pharmaceuticals operates in the chemicals industry, in the manufacturing segment.
The compliance status of Kestrel Pharmaceuticals is compliant as of 16 September 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
